|
Market Closed -
Bombay S.E.
06:21:13 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 447.70 INR | +10.98% |
|
+12.19% | +8.70% |
| 09-30 | Aarti Drugs Limited Announces Relinquishment of Adhish P. Patil as Chief Financial Officer, Effective September 30, 2026 | CI |
| 09-26 | Aarti Drugs Limited Announces Board Appointments | CI |
Company Valuation: Aarti Drugs Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 39,725 | 31,280 | 39,886 | 31,240 | 29,152 | 40,862 | - |
| Change | - | -21.26% | 27.51% | -21.68% | -6.68% | 40.17% | - |
| Enterprise Value (EV) | 39,725 | 31,280 | 39,886 | 31,240 | 29,152 | 40,862 | 40,862 |
| Change | - | -21.26% | 27.51% | -21.68% | -6.68% | 40.17% | 0% |
| P/E | 19.4x | 18.8x | 23.4x | 18.5x | 15x | - | 16x |
| PBR | 3.83x | 2.62x | 3.11x | 2.27x | 1.88x | 2.39x | 2.15x |
| PEG | - | -1x | 7.13x | -16.35x | 0.9x | - | - |
| Capitalization / Revenue | 1.6x | 1.15x | 1.58x | 1.31x | 1.14x | 1.39x | 1.25x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 1.39x | 1.25x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 10.1x | 8.8x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 12.5x | 10.8x |
| EV / FCF | -0x | -0x | 0x | 0x | 0x | 52.5x | 40x |
| FCF Yield | -1.86% | -0.97% | 3.32% | 2.16% | 2.75% | 1.9% | 2.5% |
| Dividend per Share 2 | 1 | - | 1 | - | 2 | 5.9 | 7 |
| Rate of return | 0.23% | - | 0.23% | - | 0.63% | 1.32% | 1.56% |
| EPS 2 | 22.12 | 17.97 | 18.56 | 18.35 | 21.36 | - | 27.9 |
| Distribution rate | 4.52% | - | 5.39% | - | 9.36% | - | 25.1% |
| Net sales 1 | 24,886 | 27,160 | 25,286 | 23,870 | 25,653 | 29,453 | 32,686 |
| EBITDA 1 | 3,294 | 3,056 | 3,165 | 2,871 | 3,092 | 4,035 | 4,641 |
| EBIT 1 | 2,794 | 2,553 | 2,650 | 2,313 | 2,422 | 3,262 | 3,767 |
| Net income 1 | 2,050 | 1,663 | 1,714 | 1,682 | 1,949 | 2,152 | 2,546 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 429.00 | 337.80 | 433.85 | 339.80 | 319.40 | 447.70 | 447.70 |
| Nbr of stocks (in thousands) | 92,600 | 92,600 | 91,935 | 91,935 | 91,270 | 91,270 | - |
| Announcement Date | 5/9/22 | 4/29/23 | 5/3/24 | 5/6/25 | 5/15/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | 1.46% | 388M | |
| 37.66x | 13.18x | 27.98x | 0.53% | 1,143B | |
| 39.33x | 6.61x | 18.6x | 1.99% | 647B | |
| 37.45x | 8.4x | 17.37x | 2.4% | 506B | |
| 21.46x | 5.22x | 12.98x | 2.51% | 384B | |
| 103.38x | 5.8x | 24.86x | 2.4% | 350B | |
| 21.99x | 5.69x | 13.69x | 2.94% | 293B | |
| 22.31x | 4.51x | 12.87x | 1.96% | 265B | |
| 28.42x | 7.28x | 13.03x | 2.25% | 242B | |
| -45.78x | 7.1x | 27.53x | 2.07% | 197B | |
| Average | 29.58x | 7.09x | 18.77x | 2.05% | 402.79B | |
| Weighted average by Cap. | 35.27x | 8.35x | 20.48x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AARTIDRUGS Stock
- Valuation Aarti Drugs Limited
Select your edition
All financial news and data tailored to specific country editions
